Edition:
United States

People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,912.00GBp
22 Sep 2017
Change (% chg)

143.50 (+3.01%)
Prev Close
4,768.50
Open
4,813.50
Day's High
4,954.50
Day's Low
4,772.50
Volume
4,223,049
Avg. Vol
2,555,241
52-wk High
5,585.07
52-wk Low
3,996.00

Dunoyer, Marc 

Mr. Marc Dunoyer is an Executive Director, Chief Financial Officer of AstraZeneca PLC. His career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel and GlaxoSmithKline (GSK), has given him extensive industry experience, including finance and accounting; corporate strategy and planning; research and development; sales and marketing; business reorganisation; and business development. Marc qualified as an accountant and joined AstraZeneca in 2013, serving as Executive Vice-President, GPPS from June to October 2013. Prior to that, he served as Global Head of Rare Diseases at GSK and (concurrently) Chairman, GSK Japan. He holds an MBA from HEC, Paris and a Bachelor of Law degree from Paris University.

Basic Compensation

Total Annual Compensation, GBP 1,331,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP 2,878,000
All Other, GBP 241,000
Fiscal Year Total, GBP 4,450,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

611,000

Pascal Soriot

13,389,000

Marc Dunoyer

4,450,000

Fiona Cicconi

--

Sean Bohen

--

Pam Cheng

--
As Of  30 Dec 2016